Pediatric dosing of antimicrobials: Difference between revisions
From IDWiki
(→: added glycopeptides) |
(→: combined age and weight columns) |
||
Line 6: | Line 6: | ||
! Drug |
! Drug |
||
! Indication |
! Indication |
||
! Age |
! Age and weight |
||
! |
! Dose |
||
! Usual dose |
|||
|- |
|- |
||
| rowspan=2 | [[Penicillin]] G IV/IM |
| rowspan=2 | [[Penicillin]] G IV/IM |
||
| moderate to severe infections |
| moderate to severe infections |
||
⚫ | |||
| colspan=2 | |
|||
| 100,000 to 400,000 U/kg/day split q4-6h (max 24 MU/day) |
| 100,000 to 400,000 U/kg/day split q4-6h (max 24 MU/day) |
||
|- |
|- |
||
| meningitis |
| meningitis |
||
⚫ | |||
| colspan=2 | |
|||
| 400,000 U/kg/day split q4h (max 24 MU/day) |
| 400,000 U/kg/day split q4h (max 24 MU/day) |
||
|- |
|- |
||
| rowspan=6 | [[Penicillin]] VK PO |
| rowspan=6 | [[Penicillin]] VK PO |
||
| mild to moderate infections |
| mild to moderate infections |
||
⚫ | |||
| colspan=2 | |
|||
| 25-50 mg/kg/day split q8-12h |
| 25-50 mg/kg/day split q8-12h |
||
|- |
|- |
||
| rowspan=2 | rheumatic fever (treatment) |
| rowspan=2 | rheumatic fever (treatment) |
||
| rowspan=2 | |
|||
| ≤ 27 kg |
| ≤ 27 kg |
||
| 300 mg PO bid x10 days |
| 300 mg PO bid x10 days |
||
Line 34: | Line 32: | ||
| rheumatic fever (prophylaxis) |
| rheumatic fever (prophylaxis) |
||
| > 5 years |
| > 5 years |
||
⚫ | |||
| 300 mg PO bid |
| 300 mg PO bid |
||
|- |
|- |
||
| rowspan=2 | asplenia (prophylaxis) |
| rowspan=2 | asplenia (prophylaxis) |
||
| 6 months to 5 years |
| 6 months to 5 years |
||
| rowspan=2 | |
|||
| 150 mg PO bid |
| 150 mg PO bid |
||
|- |
|- |
||
Line 47: | Line 43: | ||
| [[Cloxacillin]] IV |
| [[Cloxacillin]] IV |
||
| methicillin-susceptible [[Staphylococcus aureus]] |
| methicillin-susceptible [[Staphylococcus aureus]] |
||
⚫ | |||
| colspan=2 | |
|||
| 100-200 mg/kg/day split q4-6h (max 2g/dose and 12 g/day) |
| 100-200 mg/kg/day split q4-6h (max 2g/dose and 12 g/day) |
||
|- |
|- |
||
| [[Cloxacillin]] PO |
| [[Cloxacillin]] PO |
||
| colspan= |
| colspan=2 | |
||
| use [[cephalexin]] instead |
| use [[cephalexin]] instead |
||
|- |
|- |
||
Line 57: | Line 53: | ||
| rowspan=2 | usual dose |
| rowspan=2 | usual dose |
||
| neonates |
| neonates |
||
⚫ | |||
| 100-200 mg/kg/day split q6-8h |
| 100-200 mg/kg/day split q6-8h |
||
|- |
|- |
||
| infants and children |
| infants and children |
||
⚫ | |||
| 100-200 mg/kg/day split q6h (max 2 g/dose) |
| 100-200 mg/kg/day split q6h (max 2 g/dose) |
||
|- |
|- |
||
| rowspan=2 | meningitis |
| rowspan=2 | meningitis |
||
| neonates |
| neonates |
||
⚫ | |||
| 300 mg/kg/day split q6-8h |
| 300 mg/kg/day split q6-8h |
||
|- |
|- |
||
| infants and children |
| infants and children |
||
⚫ | |||
| 300-400 mg/kg/day split q4-6h (max 2 g/dose) |
| 300-400 mg/kg/day split q4-6h (max 2 g/dose) |
||
|- |
|- |
||
| rowspan=3 | [[Amoxicillin]] PO |
| rowspan=3 | [[Amoxicillin]] PO |
||
| usual dose |
| usual dose |
||
⚫ | |||
| colspan=2 | |
|||
| 40-50 mg/kg/day split q8h |
| 40-50 mg/kg/day split q8h |
||
|- |
|- |
||
| [[Streptococcus pneumoniae]] |
| [[Streptococcus pneumoniae]] |
||
⚫ | |||
| colspan=2 | |
|||
| 80-90 mg/kg/day split q8h |
| 80-90 mg/kg/day split q8h |
||
|- |
|- |
||
| [[Group A Streptococcus]] pharyngitis |
| [[Group A Streptococcus]] pharyngitis |
||
⚫ | |||
| colspan=2 | |
|||
| 50 mg/kg once daily x10 days (max 1 g/dose) |
| 50 mg/kg once daily x10 days (max 1 g/dose) |
||
|- |
|- |
||
| rowspan=2 | [[Amoxicillin-clavulanic acid]] PO |
| rowspan=2 | [[Amoxicillin-clavulanic acid]] PO |
||
| usual dose |
| usual dose |
||
⚫ | |||
| colspan=2 | |
|||
| 30-50 mg/kg/day (amox component) split q8-12h (max 875 mg/dose) |
| 30-50 mg/kg/day (amox component) split q8-12h (max 875 mg/dose) |
||
|- |
|- |
||
| [[Streptococcus pneumoniae]] |
| [[Streptococcus pneumoniae]] |
||
⚫ | |||
| colspan=2 | |
|||
| 80-90 mg/kg/day (amox component) split q8-12h (max 875 mg/dose) |
| 80-90 mg/kg/day (amox component) split q8-12h (max 875 mg/dose) |
||
|- |
|- |
||
| rowspan=2 | [[Piperacillin-tazobactam]] IV |
| rowspan=2 | [[Piperacillin-tazobactam]] IV |
||
| usual dose |
| usual dose |
||
⚫ | |||
| colspan=2 | |
|||
| 240-300 mg/kg/day (pip component) split q6-8h |
| 240-300 mg/kg/day (pip component) split q6-8h |
||
|- |
|- |
||
| [[Pseudomonas aeruginosa]] or [[cystic fibrosis]] |
| [[Pseudomonas aeruginosa]] or [[cystic fibrosis]] |
||
⚫ | |||
| colspan=2 | |
|||
| 400 mg/kg/day split q6h |
| 400 mg/kg/day split q6h |
||
|} |
|} |
||
Line 109: | Line 101: | ||
! Drug |
! Drug |
||
! Indication |
! Indication |
||
! Age |
! Age and weight |
||
! |
! Dose |
||
! Usual dose |
|||
|- |
|- |
||
! colspan=5 | First generation |
! colspan=5 | First generation |
||
Line 117: | Line 108: | ||
| [[Cefazolin]] IV/IM |
| [[Cefazolin]] IV/IM |
||
| usual dose |
| usual dose |
||
⚫ | |||
| colspan=2 | |
|||
| 75-150 mg/kg/day split q8h (max 2 g/dose and 6 g/day) |
| 75-150 mg/kg/day split q8h (max 2 g/dose and 6 g/day) |
||
|- |
|- |
||
| rowspan=2 | [[Cephalexin]] PO |
| rowspan=2 | [[Cephalexin]] PO |
||
| usual dose |
| usual dose |
||
⚫ | |||
| colspan=2 | |
|||
| 25-100 mg/kg/day split qid |
| 25-100 mg/kg/day split qid |
||
|- |
|- |
||
| [[osteomyelitis]] (oral step-down) |
| [[osteomyelitis]] (oral step-down) |
||
⚫ | |||
| colspan=2 | |
|||
| 100-150 mg/kg/day split qid |
| 100-150 mg/kg/day split qid |
||
|- |
|- |
||
Line 133: | Line 124: | ||
| [[Cefuroxime]] IV/IM |
| [[Cefuroxime]] IV/IM |
||
| usual dose |
| usual dose |
||
⚫ | |||
| colspan=2 | |
|||
| 100-150 mg/kg/day split q8h (max 2 g/dose) |
| 100-150 mg/kg/day split q8h (max 2 g/dose) |
||
|- |
|- |
||
| [[Cefuroxime]] azetil PO |
| [[Cefuroxime]] azetil PO |
||
| colspan= |
| colspan=2 | |
||
| poor bioavailability; not recommended |
| poor bioavailability; not recommended |
||
|- |
|- |
||
| [[Cefprozil]] PO |
| [[Cefprozil]] PO |
||
| usual dose |
| usual dose |
||
⚫ | |||
| colspan=2 | |
|||
| 15-30 mg/kg/day split bid (max 1 g/day) |
| 15-30 mg/kg/day split bid (max 1 g/day) |
||
|- |
|- |
||
Line 150: | Line 141: | ||
| rowspan=3 | usual dose |
| rowspan=3 | usual dose |
||
| 0-7 days |
| 0-7 days |
||
⚫ | |||
| 50 mg/kg/dose q8h |
| 50 mg/kg/dose q8h |
||
|- |
|- |
||
| >7 days |
| >7 days |
||
⚫ | |||
| 50 mg/kg/dose q8h |
| 50 mg/kg/dose q8h |
||
|- |
|- |
||
| infants and children |
| infants and children |
||
⚫ | |||
| 100-200 mg/kg/day split q6-8h (max 6 g/day) |
| 100-200 mg/kg/day split q6-8h (max 6 g/day) |
||
|- |
|- |
||
| rowspan=3 | [[meningitis]] |
| rowspan=3 | [[meningitis]] |
||
| 0-7 days |
| 0-7 days |
||
⚫ | |||
| 50 mg/kg/dose q8h |
| 50 mg/kg/dose q8h |
||
|- |
|- |
||
| >7 days |
| >7 days |
||
⚫ | |||
| 50 mg/kg/dose q6h |
| 50 mg/kg/dose q6h |
||
|- |
|- |
||
| infants and children |
| infants and children |
||
⚫ | |||
| 200-300 mg/kg/day split q6h (max 4 g/dose and 12 g/day) |
| 200-300 mg/kg/day split q6h (max 4 g/dose and 12 g/day) |
||
|- |
|- |
||
Line 177: | Line 162: | ||
| usual dose |
| usual dose |
||
| >1 month |
| >1 month |
||
⚫ | |||
| 50-75 mg/kg q24h (max 2 g/day) |
| 50-75 mg/kg q24h (max 2 g/day) |
||
|- |
|- |
||
| [[meningitis]] |
| [[meningitis]] |
||
| >1 month |
| >1 month |
||
⚫ | |||
| 100 mg/kg/day split q12-24h (max 2 g/dose and 4 g/day) |
| 100 mg/kg/day split q12-24h (max 2 g/dose and 4 g/day) |
||
|- |
|- |
||
| rowspan=2 | [[gonorrhea]] |
| rowspan=2 | [[gonorrhea]] |
||
| ≥9 years |
| ≥9 years |
||
⚫ | |||
| 250 mg IM once |
| 250 mg IM once |
||
|- |
|- |
||
| <9 years |
| <9 years |
||
⚫ | |||
| 50 mg/kg IM once (max 250 mg) |
| 50 mg/kg IM once (max 250 mg) |
||
|- |
|- |
||
| rowspan=2 | [[Ceftazidime]] IM/IV |
| rowspan=2 | [[Ceftazidime]] IM/IV |
||
| usual dose |
| usual dose |
||
⚫ | |||
| colspan=2 | |
|||
| 75-150 mg/kg/day split q8h (max 2 g/dose and 6 g/day) |
| 75-150 mg/kg/day split q8h (max 2 g/dose and 6 g/day) |
||
|- |
|- |
||
| [[meningitis]] or [[cystic fibrosis]] |
| [[meningitis]] or [[cystic fibrosis]] |
||
| |
|||
| colspan=2 | |
|||
| 200 mg/kg/day split q6-8h (max 6 g/day) |
| 200 mg/kg/day split q6-8h (max 6 g/day) |
||
|- |
|- |
||
| [[Cefixime]] PO |
| [[Cefixime]] PO |
||
| usual dose |
| usual dose |
||
| |
|||
| colspan=2 | |
|||
| 8 mg/kg/day split q12-24h (max 400 mg/day) |
| 8 mg/kg/day split q12-24h (max 400 mg/day) |
||
|} |
|} |
||
Line 214: | Line 195: | ||
! Drug |
! Drug |
||
! Indication |
! Indication |
||
! Age |
! Age and weight |
||
! |
! Dose |
||
! Usual dose |
|||
|- |
|- |
||
| rowspan=2 | [[Meropenem]] |
| rowspan=2 | [[Meropenem]] |
||
| usual dose |
| usual dose |
||
| |
|||
| colspan=2 | |
|||
| 20 mg/kg/dose q8h (max 1 g/dose) |
| 20 mg/kg/dose q8h (max 1 g/dose) |
||
|- |
|- |
||
| [[meningitis]] |
| [[meningitis]] |
||
| |
|||
| colspan=2 | |
|||
| 40 mg/kg/dose q8h (max 2 g/dose) |
| 40 mg/kg/dose q8h (max 2 g/dose) |
||
|- |
|- |
||
Line 230: | Line 210: | ||
| rowspan=2 | usual dose |
| rowspan=2 | usual dose |
||
| 3 months to 12 years |
| 3 months to 12 years |
||
⚫ | |||
| 15 mg/kg/dose q12h (max 500 mg/dose) |
| 15 mg/kg/dose q12h (max 500 mg/dose) |
||
|- |
|- |
||
| ≥13 years |
| ≥13 years |
||
⚫ | |||
| 1 g daily |
| 1 g daily |
||
|} |
|} |
||
Line 243: | Line 221: | ||
! Drug |
! Drug |
||
! Indication |
! Indication |
||
! Age |
! Age and weight |
||
! Weight |
|||
! Usual dose |
! Usual dose |
||
|- |
|- |
||
| rowspan=2 | [[Vancomycin]] IV |
| rowspan=2 | [[Vancomycin]] IV |
||
| usual dose |
| usual dose |
||
| |
|||
| colspan=2 | |
|||
| 40-60 mg/kg/day split q6-12h (max 2+ g/day) |
| 40-60 mg/kg/day split q6-12h (max 2+ g/day) |
||
|- |
|- |
||
| [[meningitis]] or [[MRSA]] |
| [[meningitis]] or [[MRSA]] |
||
| |
|||
| colspan=2 | |
|||
| 60 mg/kg/day split q6-8h (max 4 g/day) |
| 60 mg/kg/day split q6-8h (max 4 g/day) |
||
|- |
|- |
||
| [[Vancomycin]] PO |
| [[Vancomycin]] PO |
||
| [[Clostridium difficile]] |
| [[Clostridium difficile]] |
||
| |
|||
| colspan=2 | |
|||
| 10 mg/kg/dose q6h (max 125 mg/dose) |
| 10 mg/kg/dose q6h (max 125 mg/dose) |
||
|} |
|} |
Revision as of 11:56, 18 November 2019
Antibiotics
Penicillins
Drug | Indication | Age and weight | Dose |
---|---|---|---|
Penicillin G IV/IM | moderate to severe infections | 100,000 to 400,000 U/kg/day split q4-6h (max 24 MU/day) | |
meningitis | 400,000 U/kg/day split q4h (max 24 MU/day) | ||
Penicillin VK PO | mild to moderate infections | 25-50 mg/kg/day split q8-12h | |
rheumatic fever (treatment) | ≤ 27 kg | 300 mg PO bid x10 days | |
> 27 kg | 600 mg PO bid x 10 days | ||
rheumatic fever (prophylaxis) | > 5 years | 300 mg PO bid | |
asplenia (prophylaxis) | 6 months to 5 years | 150 mg PO bid | |
> 5 years | 300 mg PO bid | ||
Cloxacillin IV | methicillin-susceptible Staphylococcus aureus | 100-200 mg/kg/day split q4-6h (max 2g/dose and 12 g/day) | |
Cloxacillin PO | use cephalexin instead | ||
Ampicillin IV | usual dose | neonates | 100-200 mg/kg/day split q6-8h |
infants and children | 100-200 mg/kg/day split q6h (max 2 g/dose) | ||
meningitis | neonates | 300 mg/kg/day split q6-8h | |
infants and children | 300-400 mg/kg/day split q4-6h (max 2 g/dose) | ||
Amoxicillin PO | usual dose | 40-50 mg/kg/day split q8h | |
Streptococcus pneumoniae | 80-90 mg/kg/day split q8h | ||
Group A Streptococcus pharyngitis | 50 mg/kg once daily x10 days (max 1 g/dose) | ||
Amoxicillin-clavulanic acid PO | usual dose | 30-50 mg/kg/day (amox component) split q8-12h (max 875 mg/dose) | |
Streptococcus pneumoniae | 80-90 mg/kg/day (amox component) split q8-12h (max 875 mg/dose) | ||
Piperacillin-tazobactam IV | usual dose | 240-300 mg/kg/day (pip component) split q6-8h | |
Pseudomonas aeruginosa or cystic fibrosis | 400 mg/kg/day split q6h |
Cephalosporins
Drug | Indication | Age and weight | Dose | |
---|---|---|---|---|
First generation | ||||
Cefazolin IV/IM | usual dose | 75-150 mg/kg/day split q8h (max 2 g/dose and 6 g/day) | ||
Cephalexin PO | usual dose | 25-100 mg/kg/day split qid | ||
osteomyelitis (oral step-down) | 100-150 mg/kg/day split qid | |||
Second generation | ||||
Cefuroxime IV/IM | usual dose | 100-150 mg/kg/day split q8h (max 2 g/dose) | ||
Cefuroxime azetil PO | poor bioavailability; not recommended | |||
Cefprozil PO | usual dose | 15-30 mg/kg/day split bid (max 1 g/day) | ||
Third generation | ||||
Cefotaxime IV/IM | usual dose | 0-7 days | 50 mg/kg/dose q8h | |
>7 days | 50 mg/kg/dose q8h | |||
infants and children | 100-200 mg/kg/day split q6-8h (max 6 g/day) | |||
meningitis | 0-7 days | 50 mg/kg/dose q8h | ||
>7 days | 50 mg/kg/dose q6h | |||
infants and children | 200-300 mg/kg/day split q6h (max 4 g/dose and 12 g/day) | |||
Ceftriaxone IM/IV | usual dose | >1 month | 50-75 mg/kg q24h (max 2 g/day) | |
meningitis | >1 month | 100 mg/kg/day split q12-24h (max 2 g/dose and 4 g/day) | ||
gonorrhea | ≥9 years | 250 mg IM once | ||
<9 years | 50 mg/kg IM once (max 250 mg) | |||
Ceftazidime IM/IV | usual dose | 75-150 mg/kg/day split q8h (max 2 g/dose and 6 g/day) | ||
meningitis or cystic fibrosis | 200 mg/kg/day split q6-8h (max 6 g/day) | |||
Cefixime PO | usual dose | 8 mg/kg/day split q12-24h (max 400 mg/day) |
Carbapenems
Drug | Indication | Age and weight | Dose |
---|---|---|---|
Meropenem | usual dose | 20 mg/kg/dose q8h (max 1 g/dose) | |
meningitis | 40 mg/kg/dose q8h (max 2 g/dose) | ||
Ertapenem | usual dose | 3 months to 12 years | 15 mg/kg/dose q12h (max 500 mg/dose) |
≥13 years | 1 g daily |
Glycopeptides
Drug | Indication | Age and weight | Usual dose |
---|---|---|---|
Vancomycin IV | usual dose | 40-60 mg/kg/day split q6-12h (max 2+ g/day) | |
meningitis or MRSA | 60 mg/kg/day split q6-8h (max 4 g/day) | ||
Vancomycin PO | Clostridium difficile | 10 mg/kg/dose q6h (max 125 mg/dose) |